Medical Products Laboratories, Inc. FDA Inspection Record

FEI 2513595 · Inspections, Form 483s, warning letters and import refusals

Medical Products Laboratories, Inc. is an FDA-registered facility (FEI 2513595) located in Philadelphia, PA, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK. RegDataLab tracks 8 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Jul 13, 2023: Voluntary Action Indicated (VAI)
Inspections on record
8 (7 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
1 listed by FDA for this FEI, latest Apr 9, 2026
Recalls as the recalling firm
2, latest Nov 12, 2025
Import refusals
10 or more

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jul 13, 2023Voluntary Action Indicated (VAI)Equipment Design, Size and Location (21 CFR 211.63)
Mar 13, 2020Voluntary Action Indicated (VAI)No citations listed
Oct 12, 2017Voluntary Action Indicated (VAI)No citations listed
Jul 21, 2015Voluntary Action Indicated (VAI)SOPs not followed / documented (21 CFR 211.100(b))
Quarantine of Rejected Components et. al. (21 CFR 211.89)
Scientifically sound laboratory controls (21 CFR 211.160(b))
Feb 24, 2014Voluntary Action Indicated (VAI)Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Absence of Written Procedures (21 CFR 211.100(a))
Procedures for non-sterile drug products (21 CFR 211.113(a))
and 10 more
Jul 13, 2011No Action Indicated (NAI)No citations listed
Apr 27, 2011Voluntary Action Indicated (VAI)Buildings not maintained in good state of repair (21 CFR 211.58)
Jun 14, 2010Voluntary Action Indicated (VAI)Equipment Design, Size and Location (21 CFR 211.63)
Absence of Written Procedures (21 CFR 211.100(a))
Procedures for non-sterile drug products (21 CFR 211.113(a))
Adequate number of batches on stability (21 CFR 211.166(b))
and 10 more

Warning letters

Letters whose text states this FEI. Many letters do not state one, so this list can be incomplete: search warning letters by company name.

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Nov 12, 2025Class IID-0179-2026Walgreens Saline Nasal Spray WITH XYLITOL, 1.5 oz (45mL) bottle, DISTRIBUTED BY: WALGREEN…
Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis
Jun 23, 2010Class IID-019-2011NaFrinse, Fluoride Mouthrinse in 10 ml cups. The product is shipped 12 x 10 ml x 24.
CGMP Deviations: Firm did not follow SOP/GMPs during manufacturing.

FDA record score

41 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

10 records behind this number
RecordDatePoints x age weightAdds
Warning letter, no close-out letter listedApr 9, 202630 x 130
Class II recall D-0179-2026, this FEI as the recalling firmNov 12, 20254 x 14
Inspection classified VAIJul 13, 20236 x 0.63.6
Inspection classified VAIMar 13, 20206 x 0.251.5
Inspection classified VAIOct 12, 20176 x 0.251.5
Inspection classified VAIJul 21, 201510 years or older, so it adds no points0
Inspection classified VAIFeb 24, 201410 years or older, so it adds no points0
Inspection classified VAIApr 27, 201110 years or older, so it adds no points0
Class II recall D-019-2011, this FEI as the recalling firmJun 23, 201010 years or older, so it adds no points0
Inspection classified VAIJun 14, 201010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Medical Products Laboratories, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Medical Products Laboratories, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Medical Products Laboratories, Inc.
Location
Philadelphia, PA (US)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK
Source
both

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.